Biophytis Secures the Manufacturing of Sarconeos (BIO101) for COVID-19 with a Global CDMO & Announces the Next Milestones for the COVA Phase 2-3 Study
The Company signed contracts for the manufacturing of registration batches in view of the potential…
Why Downtime Still Happens: Five HA Mistakes to Avoid
Senteon and Compliance Scorecard Announce Strategic Partnership to Simplify Continuous Compliance